BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Torrente L, Prieto-Farigua N, Falzone A, Elkins CM, Boothman DA, Haura EB, DeNicola GM. Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone. Redox Biol 2020;30:101440. [PMID: 32007910 DOI: 10.1016/j.redox.2020.101440] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 He Y, Guo S, Zhang Y, Liu Y, Ju H. NIR-II reinforced intracellular cyclic reaction to enhance chemodynamic therapy with abundant H2O2 supply. Biomaterials 2021;275:120962. [PMID: 34153782 DOI: 10.1016/j.biomaterials.2021.120962] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Sun S, Zhang Y, Xu W, Yang R, Yang Y, Guo J, Ma Q, Ma K, Zhang J, Xu J. Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells. Biomed Pharmacother 2021;146:112546. [PMID: 34954641 DOI: 10.1016/j.biopha.2021.112546] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shukla K, Singh N, Lewis JE, Tsang AW, Boothman DA, Kemp ML, Furdui CM. MTHFD2 Blockade Enhances the Efficacy of β-Lapachone Chemotherapy With Ionizing Radiation in Head and Neck Squamous Cell Cancer. Front Oncol 2020;10:536377. [PMID: 33262939 DOI: 10.3389/fonc.2020.536377] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Alfhili MA, Alsughayyir J, Basudan AM. Reprogramming of erythrocyte lifespan by NFκB-TNFα naphthoquinone antagonist β-lapachone is regulated by calcium overload and CK1α. J Food Biochem 2021;45:e13710. [PMID: 33749832 DOI: 10.1111/jfbc.13710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Johnson FD, Ferrarone J, Liu A, Brandstädter C, Munuganti R, Farnsworth DA, Lu D, Luu J, Sihota T, Jansen S, Nagelberg A, Shi R, Forcina GC, Zhang X, Cheng GSW, Spencer Miko SE, de Rappard-Yuswack G, Sorensen PH, Dixon SJ, Guha U, Becker K, Djaballah H, Somwar R, Varmus H, Morin GB, Lockwood WW. Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells. Cell Rep 2022;38:110343. [PMID: 35139387 DOI: 10.1016/j.celrep.2022.110343] [Reference Citation Analysis]
6 Zhao W, Jiang L, Fang T, Fang F, Liu Y, Zhao Y, You Y, Zhou H, Su X, Wang J, Liu S, Chen Y, Wan J, Huang X. β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation. Front Oncol 2021;11:747282. [PMID: 34676172 DOI: 10.3389/fonc.2021.747282] [Reference Citation Analysis]
7 DeBlasi JM, DeNicola GM. Dissecting the Crosstalk between NRF2 Signaling and Metabolic Processes in Cancer. Cancers (Basel) 2020;12:E3023. [PMID: 33080927 DOI: 10.3390/cancers12103023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
8 Zhang J, Xu Q, Ma D. Inhibition of thioredoxin reductase by natural anticancer candidate β-lapachone accounts for triggering redox activation-mediated HL-60 cell apoptosis. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.01.019] [Reference Citation Analysis]
9 Su X, Wang J, Jiang L, Chen Y, Lu T, Mendonca MS, Huang X. PCNA inhibition enhances the cytotoxicity of β-lapachone in NQO1-Positive cancer cells by augmentation of oxidative stress-induced DNA damage. Cancer Lett 2021;519:304-14. [PMID: 34329742 DOI: 10.1016/j.canlet.2021.07.040] [Reference Citation Analysis]
10 Yang Y, Sun S, Xu W, Zhang Y, Yang R, Ma K, Zhang J, Xu J. Piperlongumine Inhibits Thioredoxin Reductase 1 by Targeting Selenocysteine Residues and Sensitizes Cancer Cells to Erastin. Antioxidants 2022;11:710. [DOI: 10.3390/antiox11040710] [Reference Citation Analysis]
11 Zhang Y, Sun S, Xu W, Yang R, Yang Y, Guo J, Ma K, Xu J. Thioredoxin reductase 1 inhibitor shikonin promotes cell necroptosis via SecTRAPs generation and oxygen-coupled redox cycling. Free Radic Biol Med 2021;180:52-62. [PMID: 34973363 DOI: 10.1016/j.freeradbiomed.2021.12.314] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Harris IS, DeNicola GM. The Complex Interplay between Antioxidants and ROS in Cancer. Trends Cell Biol 2020;30:440-51. [PMID: 32303435 DOI: 10.1016/j.tcb.2020.03.002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 30.0] [Reference Citation Analysis]
13 Jiang C, P Ward N, Prieto-Farigua N, Kang YP, Thalakola A, Teng M, M DeNicola G. A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer. Redox Biol 2022;54:102358. [PMID: 35667246 DOI: 10.1016/j.redox.2022.102358] [Reference Citation Analysis]